Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India · Delayed Price · Currency is INR 0.2800
0.00 (0.00%)
At close: Jun 17, 2026
BOM:524661 Revenue
In the fiscal year ending March 31, 2026, Welcure Drugs and Pharmaceuticals had annual revenue of 3.66B INR with 1,388.95% growth.
Revenue
3.66B
Revenue Growth
+1,388.95%
P/S Ratio
0.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
346.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.66B | 3.41B | 1,388.95% |
| Mar 31, 2025 | 245.50M | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 1.05M | -283.43K | -21.26% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.43B |
| JFL Life Sciences | 1.31B |
| ANG Lifesciences India | 862.13M |
| Deccan Health Care | 819.05M |
| Sandu Pharmaceuticals | 699.35M |
| Panjon | 476.21M |